Enveric’s lead candidate, EB-003, is a novel neuroplastogen that engages both the 5-HT2A and 5-HT1B receptors, a dual mechanism that may define a new class of neuropsychiatric treatments. This pharmacological profile is designed to promote adaptive rewiring of brain circuits while stabilizing emotional and behavioral regulation, potentially enabling durable recovery in patients with post-traumatic stress disorder (PTSD), treatment-resistant […]

A conversation with Joseph Tucker, Ph.D., CEO, Enveric Biosciences. The White House recently issued an executive order accelerating the use of psychedelics, such as psilocybin, MDMA, and ibogaine, in research and clinical trials. This order, however, does not change the current legal status of any of them.

Enveric Biosciences Inc. (NASDAQ:ENVB) on Tuesday highlighted preclinical findings for its lead candidate EB-003. It pointed to rapid reductions in PTSD-related fear responses, as recent federal policy signals growing support for psychedelic-based mental health treatments.

The White House recently issued an executive order accelerating the use of psychedelics, such as psilocybin, MDMA, and ibogaine, in research and clinical trials. This order, however, does not change the current legal status of any of them.

The U.S. FDA has fast-tracked the review of three psychedelic drugs being developed to treat depression, PTSD, and other mental health conditions. CGTN’s Sean Callebs spoke with Dr. Robert Discordia, Co-Founder and CEO of Equulus Therapeutics, about the science, the politics, and what accelerated approval could mean for patients.

After more than two years offline, Panama’s largest copper mine is edging back into the global supply conversation. In January, Panamanian President José Raúl Mulino said he expects to announce by June the government’s decision whether or not to reopen Cobre Panama. A full reopening would restore a major source of copper to a constrained […]

The 28-year-old beauty mogul has worn some stunning dresses already this year, such as a custom ruby red Schiaparelli gown featuring a signature “keyhole” cutout and a plunging neckline to the Oscars, and a custom gold sequin Ashi Studio gown with a sweetheart neckline, which made Kylielook like a glittering trophy.

Non-hallucinogenic neuroplastogens are being developed as a potentially safer alternative to psychedelics, with a lower risk of hallucinations. Enveric Biosciences is developing a derivative designed to preserve signaling associated with therapeutic neuroplasticity while potentially reducing hallucinogenic risk.

While plastic surgery experts noted genetics play a key role in individual aging, they suggested Moore’s fresh face could also be attributed to a strict routine of advanced cosmetic treatments. Dr. Tia Liu, MD MSc, who has not personally treated the actress, told RadarOnline.com the “uniform luminosity people notice typically comes from consistent medical grade […]

In biotech, competitive lines are often drawn in the lab. Increasingly, they are drawn in patent court. This week, Enveric Biosciences announced that a Post Grant Review petition filed against its U.S. Patent No. 12,138,276 has been formally withdrawn. The petition, initially filed by Gilgamesh Pharmaceuticals, was later inherited by AbbVie Inc. following AbbVie’s acquisition […]